Sun Pharma Raises Rs 10,000 Crore in Debt to Fund Organon Acquisition
Sun Pharmaceutical Industries is raising Rs 10,000 crore through two tranches of rupee-denominated bonds to partly refinance bridge loans linked to the proposed acquisition of Organon.